20.95000 EUR
0.845
3.88%
Last update Dec 18, 7:37 PM CET
Market closed
Day range
20.95000
21.66000
Previous close
21.79500
Open
21.375
Access this stock data via API
Subscribe
Apellis Pharmaceuticals Inc.
20.95
0.85
3.88%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 666.1M 396.6M 75.4M 66.6M
Cost of revenue 100.4M 58.5M 5.6M 5.2M
Gross profit 565.7M 338.1M 69.8M 61.4M
Operating expense
Research & development 279.3M 354.4M 387.2M 420.9M
Selling general and admin 427.1M 500.8M 277.2M 176.8M
Other operating expenses
Operating income -140.6M -517.1M -594.6M -536.3M
Non operating interest income
Income 10.9M 20.9M 8.9M 418K
Expense 34.4M 29.6M 32.6M 13.2M
Other income expense -3.5M -727K -33.2M -196.9M
Pretax income -167.7M -526.5M -651.5M -746.0M
Tax provision 990.6K 2.1M 669K 352K
Net income -168.7M -528.6M -652.2M -746.4M
Basic EPS -1.6 -4.5 -6.2 -8.8
Diluted EPS -1.6 -4.5 -6.2 -8.8
Basic average shares 105.6M 123.2M 110.7M 88.1M
Diluted average shares 105.6M 123.2M 110.7M 88.1M
EBITDA -130.1M -495.2M -584.5M -533.0M
Net income from continuing op. -168.7M -528.6M -652.2M -746.4M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 43 minutes

07:16
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).